{"py/object": "rasa.core.featurizers.tracker_featurizers.MaxHistoryTrackerFeaturizer", "state_featurizer": {"py/object": "rasa.core.featurizers.single_state_featurizer.SingleStateFeaturizer", "_default_feature_states": {"intent": {"ABG in CD": 0, "ABI in PAD": 1, "APOE in CD": 2, "Beta blockers in CD": 3, "CKD contribution": 4, "CRISPR": 5, "CRP in CD": 6, "CSVD contribution": 7, "CT aniography vs conventional aniography": 8, "CTEPH  differ from other forms": 9, "CTEPH and IPH": 10, "CTPA in pulmonary embolism": 11, "DVT to PE": 12, "D_dimer testing": 13, "ECG report": 14, "EGDT in septic": 15, "ETCO2 level assist": 16, "FFR in CD": 17, "FFRCT in treatments": 18, "HFpEF mimic heart failure": 19, "HRV in CD": 20, "INOCA patients": 21, "LGE effect": 22, "Lbbb block MD": 23, "MRI in identifying MD": 24, "MitraClip procedure": 25, "NAFLD contribution": 26, "OSA contribution to hypertension": 27, "PFO closure": 28, "Q waves in ECG": 29, "SGLT2 in CD": 30, "ST2 and galectin3": 31, "Systolic diastolic dysfunction": 32, "TBI to improve accuracy in PAD": 33, "TCD access cerebrovascular reserve capacity": 34, "TVR in elderly patients": 35, "Takotsubo cardiomypathy": 36, "VADS enhance survival rates": 37, "adipose tissue function": 38, "affect of psychosocial stress": 39, "affirm": 40, "antiplatelet therapy": 41, "arial fibrillations in embolic": 42, "atrial septal aneurysm": 43, "back": 44, "bot_challenge": 45, "cardioprotective mechanisms of SGLT2": 46, "care testing improve diagnosis": 47, "causes for HD": 48, "celebral autoregulation in ischemic stroke": 49, "cholestrol and HD": 50, "chronic hyperglycemia and diabetic cardiomyopathy": 51, "common_to_male_or_female": 52, "coronary slow flow phenomenon": 53, "coronary vasospastic angina": 54, "cryptogenic strokes": 55, "deny": 56, "detection of pathogenic variants in the TTN gene": 57, "diabetes and HD": 58, "diagnosing criteria": 59, "difference between cardiac and non cardiac pain": 60, "doppler ultrasound in ID": 61, "echocardiography in Ischemic": 62, "endothelial dysfunction and vascular disease": 63, "endothelin receptors in PAH": 64, "familial hypercholesterolemia": 65, "gene environment in hypertension": 66, "genetics and HD": 67, "glucocorticoids affect in HD": 68, "goodbye": 69, "greet": 70, "hw to prevent": 71, "hypercholesterolemia in CD": 72, "hypertension": 73, "hypertension treatments": 74, "hypothyroidism contribution to atherosclerosis": 75, "impact of AGEs": 76, "impedance cardiography": 77, "incretin based therapies": 78, "inform_heart_disease": 79, "insulin resistance in endothelial dysfunction": 80, "intermittent fasting effects": 81, "lactate clearence in sepsis": 82, "lactate levels in MD": 83, "lipid  panel in CD": 84, "lipoprotein in LDL": 85, "lipoprotein levels in CD": 86, "manage atrial fibrillations": 87, "mechanical thrombectomy": 88, "mitochondrial dysfunction": 89, "mood_great": 90, "mood_unhappy": 91, "nations affected": 92, "neuroimaging differentiate": 93, "nlu_fallback": 94, "out_of_scope": 95, "perfusion weighted MRI": 96, "permissive hypertension in hemorrhagic shock": 97, "pharmacogenomics in CD": 98, "pharmacogenomics in hyperlimidia": 99, "polygenic risk": 100, "pulmonary edema": 101, "restart": 102, "right catherization": 103, "role ECMO": 104, "role of NOACs": 105, "role of PCI": 106, "role of omega3 fatty acids": 107, "session_start": 108, "smoking to HD": 109, "spirometry": 110, "symptoms of HD": 111, "therapies for PAH": 112, "troponin I and troponin T in MD": 113, "troponin levels": 114, "types of HD": 115, "use of AI in wearables": 116, "venous stasis in CVI": 117, "what is CAD": 118, "what types tests": 119}, "action_name": {"action_listen": 0, "action_restart": 1, "action_session_start": 2, "action_default_fallback": 3, "action_deactivate_loop": 4, "action_revert_fallback_events": 5, "action_default_ask_affirmation": 6, "action_default_ask_rephrase": 7, "action_two_stage_fallback": 8, "action_unlikely_intent": 9, "action_back": 10, "...": 11, "action_extract_slots": 12, "utter_ HFpEF_mimic_heart_failure": 13, "utter_ABG_CD": 14, "utter_ABI_in_PAD": 15, "utter_APOE_in_CD": 16, "utter_CKD_contribution": 17, "utter_CRISPR": 18, "utter_CRP_in_CD": 19, "utter_CSVD_contribution": 20, "utter_CTEPH_and_IPH": 21, "utter_CTEPH_differ_from_other_forms": 22, "utter_CTPA_in_pulmonary_embolism": 23, "utter_DVT_in_PE": 24, "utter_D_dimer_testing": 25, "utter_ECG_report": 26, "utter_EGDT_in_septic": 27, "utter_ETCO2_level_assist": 28, "utter_FFRCT_in_treatments": 29, "utter_FFR_in_CD": 30, "utter_HRV_in_CD": 31, "utter_INOCA_patients": 32, "utter_LGE_effect": 33, "utter_Lbbb_block_MD": 34, "utter_MRI_in_identifying_MD": 35, "utter_MitraClip_procedure": 36, "utter_NAFLD_contribution": 37, "utter_OSA_contribution": 38, "utter_PFO_closure": 39, "utter_Q_waves_in_ECG": 40, "utter_SGLT2_in_CD": 41, "utter_ST2_and_galectin3": 42, "utter_Systolic_diastolic_dysfunction": 43, "utter_TBI_to_improve_accuracy_in_PAD": 44, "utter_TCD_access_cerebrovascular_reserve_capacity": 45, "utter_TVR_in_elderly_patients": 46, "utter_Takotsubo_cardiomypathy": 47, "utter_VADS_enhance_survival_rates": 48, "utter_about_CAD": 49, "utter_adipose_tissue_function": 50, "utter_affect_of_psychosocial_stress": 51, "utter_antiplatelet_therapy": 52, "utter_arial_fibrillations_in_embolic": 53, "utter_atrial_septal_aneurysm": 54, "utter_betablocker_in_CD": 55, "utter_cardiac_and_non": 56, "utter_cardioprotective_mechanisms_of_SGLT2": 57, "utter_care_testing_improve_diagnosis": 58, "utter_celebral_autoregulation_in_ischemic_stroke": 59, "utter_cheer_up": 60, "utter_cholestrol_HD": 61, "utter_chronic_hyperglycemia_and_diabetic_cardiomyopathy": 62, "utter_common_among_who": 63, "utter_common_causes_for_HD": 64, "utter_conventional_aniography": 65, "utter_coronary_slow_flow_phenomenon": 66, "utter_coronary_vasospastic_angina": 67, "utter_cryptogenic_strokes": 68, "utter_detection_of_pathogenic_variants_in_the_TTN_gene": 69, "utter_diagnosis_criteria": 70, "utter_did_that_help": 71, "utter_doppler_ultrasound_in_ID": 72, "utter_echocardiography_in_Ischemic": 73, "utter_endothelial_dysfunction_and_vascular_disease": 74, "utter_endothelin_receptors_in_PAH": 75, "utter_familial_hypercholesterolemia": 76, "utter_gene_environment_in_hypertension": 77, "utter_genetic_to_HD": 78, "utter_glucocorticoids_affect_in_HD": 79, "utter_goodbye": 80, "utter_greet": 81, "utter_happy": 82, "utter_hw_to_prevent": 83, "utter_hypercholesterolemia_in_CD": 84, "utter_hypertension": 85, "utter_hypothyroidism_contribution_to_atherosclerosis": 86, "utter_iamabot": 87, "utter_impact_of_AGEs": 88, "utter_impedance_cardiography": 89, "utter_incretin_based_therapies": 90, "utter_inform_heart_disease": 91, "utter_insulin_resistance_in_endothelial_dysfunction": 92, "utter_intermittent_fasting_effects": 93, "utter_lactate_clearence_in_sepsis": 94, "utter_lactate_levels_in_MD": 95, "utter_lipid_panel_in_CD": 96, "utter_lipoprotein_in_LDL": 97, "utter_lipoprotein_levels_in_CD": 98, "utter_manage_atrial_fibrillation": 99, "utter_mechanical_thrombectomy": 100, "utter_mitochondrial_dysfunction": 101, "utter_most_affected": 102, "utter_neuroimaging_differentiate": 103, "utter_perfusion_weighted_MRI": 104, "utter_permissive_hypertension_in_hemorrhagic_shock": 105, "utter_pharmacogenomics_in_CD": 106, "utter_pharmacogenomics_in_hyperlimidia": 107, "utter_polygenic_risk": 108, "utter_pulmonary edema": 109, "utter_relation_to_diabetes": 110, "utter_right_catherization": 111, "utter_role_ECMO": 112, "utter_role_of_NOACs": 113, "utter_role_of_PCI": 114, "utter_role_of_omega3_fatty_acids": 115, "utter_smoking_to_HD": 116, "utter_spirometry": 117, "utter_symptoms_of_HD": 118, "utter_therapies_for_PAH": 119, "utter_treatment_hypertension": 120, "utter_troponin_I_and_troponin_T_in_MD": 121, "utter_troponin_levels": 122, "utter_types_of tests": 123, "utter_types_of_HD": 124, "utter_use_of_AI_in_wearables": 125, "utter_venous_stasis_in_CVI": 126}, "entities": {}, "slots": {}, "active_loop": {}}, "action_texts": [], "entity_tag_specs": []}, "max_history": 5, "remove_duplicates": true}